安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Deutetrabenazine: Uses, Dosage, Side Effects, Warnings - Drugs. com
Deutetrabenazine (Austedo and Austedo XR) are used to treat involuntary movement disorders in tardive dyskinesia (TD) and Huntington's disease (Huntington's chorea) to help reduce the severity of symptoms and improve quality of life
- Deutetrabenazine - Wikipedia
Deutetrabenazine, sold under the brand names Austedo and Austedo XR, is a vesicular monoamine transporter 2 inhibitor which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia
- Deutetrabenazine (oral route) - Side effects dosage
Deutetrabenazine is used to treat movement disorders, including tardive dyskinesia and chorea caused by Huntington's disease Deutetrabenazine works in the central nervous system (CNS) to prevent the absorption of certain chemicals (eg, dopamine, serotonin, norepinephrine, histamine)
- AUSTEDO (deutetrabenazine) tablets, for oral use
AUSTEDO can increase the risk of depression and suicidal thoughts and behavior (suicidality) in patients with Huntington’s disease Anyone considering the use of AUSTEDO must balance the risks of
- AUSTEDO XR®: Tardive Dyskinesia and Huntington’s Chorea Treatment
AUSTEDO XR® (deutetrabenazine) extended-release tablets are approved to treat both Tardive Dyskinesia (TD) and Huntington’s disease chorea See safety info including Boxed Warning
- Austedo (deutetrabenazine) - Uses, Side Effects, and More
Find patient medical information for Austedo (deutetrabenazine) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
- Deutetrabenazine: MedlinePlus Drug Information
Deutetrabenazine is used to treat chorea (sudden movements that you cannot control) caused by Huntington's disease (an inherited disease that causes the progressive breakdown of nerve cells in the brain)
- Deutetrabenazine | C19H27NO3 | CID 73442840 - PubChem
Deutetrabenazine is a novel, highly selective vesicular monoamine transporter 2 (VMAT2) inhibitor indicated for the management of chorea associated with Huntington’s disease It is a hexahydro-dimethoxybenzoquinolizine derivative and a deuterated [DB04844]
|
|
|